Parameter
| Biomarker | MALAT1 | Full name | Metastasis-Associated Lung Adenocarcinoma Transcript 1 | Molecular Type | Nucleic acid (lncRNA) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Dassatinib resistance prediction |
| Disease | Chronic Myeloid Leukemia(CML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Patient samples (bioinformatics analysis, differential expression gene screening) | ||
| Pathobiological Mechanisms | May exert tumor-suppressive effects and be associated with the development of dafatinib resistance in CML | ||||
| Clinical Availability Status | Research validation: Predicting their functions by constructing lncRNA-miRNA-mRNA networks. | ||||
| Notes and Dynamics | To provide guidance for the research on the resistance mechanism of dasatinib and the development of therapeutic targets. | ||||